Management of Heart Failure With Reduced Ejection Fraction in Patients With Diabetes Mellitus and Chronic Kidney Disease
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Management of Heart Failure With Reduced Ejection Fraction in Patients With Diabetes Mellitus and Chronic Kidney Disease
Authors
Keywords
-
Journal
SEMINARS IN NEPHROLOGY
Volume 43, Issue 3, Pages 151429
Publisher
Elsevier BV
Online
2023-10-21
DOI
10.1016/j.semnephrol.2023.151429
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Evidence-Based Medical Therapy in Patients With Heart Failure With Reduced Ejection Fraction and Chronic Kidney Disease
- (2022) Iris E. Beldhuis et al. CIRCULATION
- Sodium-Glucose Cotransporter 2 Inhibitors and Risk of Hyperkalemia in People With Type 2 Diabetes: A Meta-Analysis of Individual Participant Data From Randomized, Controlled Trials
- (2022) Brendon L. Neuen et al. CIRCULATION
- Initial Decline ("dip") in Estimated Glomerular Filtration Rate Following Initiation of Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction: Insights from DAPA-HF.
- (2022) Carly Adamson et al. CIRCULATION
- 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure
- (2022) Paul A. Heidenreich et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Optimizing Foundational Therapies in Patients With HFrEF
- (2022) Abhinav Sharma et al. JACC-Basic to Translational Science
- Initial eGFR Changes with Ertugliflozin and Associations with Clinical Parameters: Analyses from the VERTIS CV Trial
- (2022) David Z.I. Cherney et al. AMERICAN JOURNAL OF NEPHROLOGY
- Quantifying Individual-Level Inaccuracy in Glomerular Filtration Rate Estimation
- (2022) Tariq Shafi et al. ANNALS OF INTERNAL MEDICINE
- Can We Stop Reflexively Discontinuing Mineralocorticoid Antagonists for Patients With Heart Failure and Hyperkalemia?
- (2022) IOANNIS MASTORIS et al. JOURNAL OF CARDIAC FAILURE
- Quadruple Medical Therapy for Heart Failure
- (2021) Stephen J. Greene et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Patiromer for the management of hyperkalaemia in patients receiving renin–angiotensin–aldosterone system inhibitors for heart failure: design and rationale of the DIAMOND trial
- (2021) Javed Butler et al. EUROPEAN JOURNAL OF HEART FAILURE
- Chlorthalidone for Hypertension in Advanced Chronic Kidney Disease
- (2021) Rajiv Agarwal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Comparison of creatinine‐based methods for estimating glomerular filtration rate in patients with heart failure
- (2020) Anna Jonsson et al. ESC Heart Failure
- Renal safety and efficacy of angiotensin receptor‐neprilysin inhibitor: A meta‐analysis of randomized controlled trials
- (2020) Yu Feng et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Association between sodium-glucose cotransporter 2 (SGLT2) inhibitors and lower extremity amputation: A systematic review and meta-analysis
- (2020) James Heyward et al. PLoS One
- What Makes Sodium-Glucose Co-Transporter-2 Inhibitors Stand out in Heart Failure?
- (2020) Muhammad Shahzeb Khan et al. Current Diabetes Reports
- Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure
- (2020) Milton Packer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Heart Failure Hospitalization and Guideline-Directed Prescribing Patterns Among Heart Failure With Reduced Ejection Fraction Patients
- (2020) Pratyaksh K. Srivastava et al. JACC-Heart Failure
- Characterization and implications of the initial estimated glomerular filtration rate ‘dip’ upon sodium-glucose cotransporter-2 inhibition with empagliflozin in the EMPA-REG OUTCOME trial
- (2020) Bettina J. Kraus et al. KIDNEY INTERNATIONAL
- Renal function stratified dose comparisons of eplerenone versus placebo in the EMPHASIS‐HF trial
- (2019) João Pedro Ferreira et al. EUROPEAN JOURNAL OF HEART FAILURE
- Novel potassium binders as enabling therapy in heart failure
- (2019) Javed Butler et al. EUROPEAN JOURNAL OF HEART FAILURE
- Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
- (2019) John J.V. McMurray et al. NEW ENGLAND JOURNAL OF MEDICINE
- Kidney outcomes associated with use of SGLT2 inhibitors in real-world clinical practice (CVD-REAL 3): a multinational observational cohort study
- (2019) Hiddo J L Heerspink et al. Lancet Diabetes & Endocrinology
- Clinical Events After Discontinuation of β‐Blockers in Patients Without Heart Failure Optimally Treated After Acute Myocardial Infarction
- (2018) Anke Neumann et al.
- Clinical Events After Discontinuation of β‐Blockers in Patients Without Heart Failure Optimally Treated After Acute Myocardial Infarction
- (2018) Anke Neumann et al. Circulation-Cardiovascular Quality and Outcomes
- Renal Effects and Associated Outcomes During Angiotensin-Neprilysin Inhibition in Heart Failure
- (2018) Kevin Damman et al. JACC-Heart Failure
- Angiotensin–Neprilysin Inhibition in Acute Decompensated Heart Failure
- (2018) Eric J. Velazquez et al. NEW ENGLAND JOURNAL OF MEDICINE
- Long-Standing Problem of β-Blocker–Elicited Hypoglycemia in Diabetes Mellitus
- (2017) Edoardo Casiglia et al. HYPERTENSION
- Impact of admission serum potassium on mortality in patients with chronic kidney disease and cardiovascular disease
- (2017) W Cheungpasitporn et al. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE
- Effect of sacubitril/valsartan versus enalapril on glycaemic control in patients with heart failure and diabetes: a post-hoc analysis from the PARADIGM-HF trial
- (2017) Jelena P Seferovic et al. Lancet Diabetes & Endocrinology
- Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure
- (2014) John J.V. McMurray et al. NEW ENGLAND JOURNAL OF MEDICINE
- Current Perspectives on Hydralazine and Nitrate Therapies in Heart Failure
- (2014) Robert T. Cole et al. Heart Failure Clinics
- Effects of enalapril in systolic heart failure patients with and without chronic kidney disease: Insights from the SOLVD Treatment trial
- (2012) C. Barrett Bowling et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Efficacy and Safety of Carvedilol in Treatment of Heart Failure with Chronic Kidney Disease
- (2010) Ravinder K. Wali et al. Circulation-Heart Failure
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More